21-gene recurrence assay in patients receiving intraoperative radiotherapy: are “favorable” characteristics a surrogate for low recurrence?

BACKGROUND: Intraoperative radiotherapy (IORT) has gained momentum for early stage and favorable breast cancers (BC). The 21-gene recurrence assay guides treatment of hormone positive and node-negative BC. METHODS: Analysis of 82 invasive BC treated with breast conservation surgery (BCS) and IORT 20...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gland Surg
Main Authors: Oppong, Bridget A., Sen Gupta, Surupa, Gary, Monique, Wehner, Patricia, Mete, Mihriye, Zhao, Danjing, Seevaratnam, Sulakshana, Rudra, Sonali, Willey, Shawna C.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750322/
https://ncbi.nlm.nih.gov/pubmed/29302485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs.2017.07.05
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados